- Longtime Missouri hospital CEO retires
- 6 Texas physicians to pay $5M to settle false claims allegations
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- 12 dental technology updates to know
- Imagen Dental Partners adds California practice
- 5 healthcare roles with the most signing bonuses: Indeed
- South Carolina’s largest independent multispecialty group acquired
- Gastroenterology and private equity in 2026: 5 notes
- How Sutter Health is turning AI into a people-first transformation engine
- WHO calls for environmentally friendly, less invasive dental care: 5 notes
- The GI physician shortage by state, by 2036
- GLP-1s tied to higher osteoporosis risk, studies suggest
- ASC vs. HOPD costs for 5 orthopedic procedures
- The Perfect Fit: How Health Systems Are Improving OR Performance with Application-Specific Gloves.
- 41 leaders dispel healthcare’s biggest AI myths
- Demand for nonclinical roles in healthcare drops: Indeed
- 9 health systems moving to Epic
- Federal lawmakers introduce bill to reverse Medicaid cuts, expand Medicare dental coverage: 4 notes
- Maryland awards $1.6M for substance use disorder, peer recovery workforce expansion
- SSM Health adds gastroenterologist
- South Carolina hospital taps chief nurse
- 3 new ASCs in Florida
- UChicago Medicine develops mRNA therapy for Type 1 diabetes
- Kaiser Permanente gets green light for 160K-square-foot ASC
- Mount Sinai, Saudi university partner on familial IBD research
- San Diego provider opens 32-bed residential mental health facility
- AI Therapist? It Falls Short, a New Study Warns
- Nevada hospital to downsize, switch to rural emergency status
- Mental health providers subject to ban on youth ‘transition’ procedures: Texas attorney general
- Moody’s downgrades Arkansas system’s credit rating
- 5 gastroenterologist moves in 1 month
- Innovate 32 continues growth, adds 2 dental practices in Tennessee
- Indiana hospital transitions revenue cycle operations to Revology
- Mayo Clinic posts 6.8% margin in 2025
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Corewell Health posts 1.6% operating margin, grows revenue to $17.6B — 7 things to know
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Federal Aid for Lead Cleanup Is Receding. That’s a Problem for Cash-Strapped Cities.
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- OhioHealth builds well-being programs to reshape caregiver culture
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- New Jersey woman charged with practicing unlicensed dentistry
- 100+ organizations call on CMS to revise 2027 MA rates
- Oklahoma advances interstate compact bill
- UNC Health Appalachian offers psychiatric physician training program
- Former PepperPointe Partnerships COO joins DPO
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- In 1 state, large hospitals dominate 340B's net savings
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Families Defend Disability Services Amid Medicaid Cuts
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- Blood Test Can Predict Short-Term Survival Among Seniors
- How the Brain Learns to Have Seizures During Sleep
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- Lake Nona Impact Forum: There can't be longevity without tech
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Partnering to Advance Drug Delivery Innovation
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
CCHFreedom reports the FDA trial no one else wants to touch in the US Court of Appeals for the Fifth Circuit in Louisiana.
From this week's newsletter.
Curious to know if these plaintifs are part of Front Line Docs.
FDA on Trial for Deadly Ivermectin Lies
FDA Claims Scientific Evidence Not Required to Make “Scientific” Claims
The FDA is rightly on trial for their deadly actions related to ivermectin. This quick 49-minute court hearing on August 8, 2023 — Apter vs. HHS, filed by Drs. Apter, Bowden, and Marik — was instructive and astonishing.
Several times, the judges had to insist that the FDA’s attorney, Ashley Cheung Honold, answer a question rather than obfuscate.
As Jared Kelson, the attorney for the three physicians (plaintiffs) said, “The fundamental issue in this case is straight forward.” He noted that nearly 40% of prescriptions prescribed in the U.S. are for off-label use and said: “After the FDA approves a human drug for sale, does it then have authority to influence or interfere with how the drug is used within the patient-doctor relationship? The answer is no.” He further stated that Congress prohibited it.
But the FDA’s attorney, who carefully referred only to ivermectin for animals as though that will exempt them from the impact their statements had on availability of ivermectin for humans, made several astonishing claims:
JUST HAVING FUN: The FDA’s “You’re not a horse…Stop it” tweet was “merely quips.”
NOT A COMMAND: “In some contexts those words could be construed as a command, but in this context where FDA was simply using these words as a quippy tweet meant to share its information article, those words do not rise to the level of a command.”
NO SCIENTIFIC PROCESS: Regularly claimed to the judges that scientific analysis of ivermectin had been performed but then admitted, “I don’t think there’s anything in the record that specifically tracked FDA’s process.”
NOT YOUR BUSINESS: “It’s not the role of the court to police the statements of an agency charged by Congress with making sure that drugs are safe or effective.” [Since ivermectin is safe and effective, why not say so?]
ROGUE: When challenged about the FDA’s authority to give its views, whether scientifically tested or not, “There’s nothing in the multiple sources of authority that I’ve cited that require FDA to go through any formal process.”
MEDICAL ADVICE: “No, your honor, the government is not conceding [that it cannot give medical advice]…It is not only permissible, but it is imperative that the FDA be able to inform the public about their scientific view about safe uses of drugs.”
WE HAD NOTHING TO DO WITH IT: When asked if FDA had obligation to speak up when hearing that hospitals and pharmacies were denying ivermectin based on FDA’s statements: “No, your honor, those hospitals and pharmacies are sophisticated independent third parties who are not controlled by the FDA.”
COURT HAVE NO ROLE: When asked who should hold FDA accountable if courts can’t: “The public can elect its government officials and FDA like other government agencies have politically accountable heads of the agency who are held accountable by the political process. It’s not the role of the courts to fact-check the FDA’s scientific statements meant to further their mission to protect the public from dangerous use of this drug.”
If the judges’ questions are any indication, the physicians will win in this case. Stay tuned. I expect this case to be appealed, whatever the decision. To hear the FDA’s attorney making these audacious claims of authority and innocence, start at the 17:30 minute mark.Good News on Ivermectin Safety
The FDA knew how safe ivermectin was. And now, a first-ever study verifies thesafety of ivermectin. An April 2023 study of ivermectin poisoning out of Cameroon found that a young woman trying to commit suicide took 400 pills of ivermectin (3 mg/each), which is about 100 times the recommended dose. Her neurological and gastric symptoms were treated at the hospital for five days and she was released. She has passed the baccalaureate test and entered the university.
Full newsletter, internal link to the trial video, and more information about CCHF here.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















